IP Library › Granted Patent US 7,344,886
Granted Patent B2
US 7,344,886 · App. 10/724,301 · Granted Mar 18, 2008

Neomycin-phosphotransferase-genes and methods for the selection of recombinant cells producing high levels of a desired gene product

Assignee: Boehringer Ingelheim Pharma GmbH & Co., KG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,344,886
App. No.
10/724,301
Granted
Mar 18, 2008
Kind
B2
Abstract

The invention relates to modified neomycin phosphotransferase genes and their use in a selection method for high-producing recombinant cells. The invention further relates to expression vectors which contain a modified neomycin phosphotransferase gene and a gene of interest functionally linked to a heterologous promoter and a method of preparing heterologous gene products using these expression vectors.

Claims (13)

1. A modified neomycin phosphotransferase gene wherein the modified neomycin phosphotransferase gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 2 with the modification that the amino acid at position 91 and/or 198 and or 240 is a different amino acid than that of SEQ ID NO:2.

2. The modified neomycin phosphotransferase gene according to claim 1 , wherein the encoded polypeptide has a lower enzyme activity than the polypeptide with the amino acid sequence of SEQ ID NO:2.

3. The modified neomycin phosphotransferase gene according to claim 1 wherein the modified neomycin phosphotransferase gene encodes an alanine at amino acid position 91 and/or glycine at amino acid position 198 and/or isoleucine at amino acid position 240.

4. The modified neomycin phosphotransferase gene according to claim 1 wherein the modified neomycin phosphotransferase gene encodes a polypeptide comprising an amino acid sequence according to SEQ ID NO:6, SEQ ID NO:8 or SEQ ID NO:18.

5. The modified neomycin phosphotransferase gene according to claim 1 comprising a sequence according to SEQ ID NO:5, SEQ ID NO:7 or SEQ ID NO:17.

6. A modified neomycin phosphotransferase encoded by a modified neomycin phosphotransferase gene according to claim 1 .

7. A eukaryotic expression vector containing a modified neomycin phosphotransferase gene according to claim 1 .

8. The expression vector according to claim 7 , wherein the modified neomycin phosphotransferase gene encodes a protein comprising an amino acid sequence according to SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:18.

9. A mammalian cell in vitro containing a modified neomycin phosphotransferase gene according to claim 1 .

10. A method of enriching for a mammalian cells that express a modified neomycin-phosphotransferase gene, comprising:

(i) transfecting a pool of mammalian cells with a gene for a modified neomycin-phosphotransferase according to claim 1 ;

(ii) cultivating the mammalian cells under conditions which allow expression of the modified neomycin-phosphotransferase gene; and

(iii) cultivating the mammalian cells in the presence of at least one selecting agent which acts selectively on the growth of mammalian cells, and gives preference to the growth of the cells which express the modified neomycin-phosphotransferase gene.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2004
From: ENENKEL, BARBAR; FEIDER, JUERGEN; OTTO, RALF; SAUTTER, KERSTIN; BEGEMANN, KLAUS
To: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
Reel/Frame 015020/0843 →
Priority Claims (2)
DE 102 56 081 · Nov 29, 2002 · national
DE 103 30 686 · Jul 8, 2003 · national
Continuity (3)
Provisional Application 6048790200 · Jul 17, 2003
Provisional Application 6043153500 · Dec 6, 2002
Related Publication 20050106580A1 · May 19, 2005